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Abstract
The LEW/Ztm-ci2 rat is an animal model for syndromal deafness that arose from a spontaneous mutation. Homozygous
animals show locomotor abnormalities like lateralized circling behavior. Additionally, an impaired vision can be observed in
some animals through behavioral studies. Syndromal deafness as well as retinal degeneration are features of the Usher
syndrome in humans. In the present study, the mutation was identified as a base substitution (T-.C) in exon 56 of Myo15,
leading to an amino acid exchange from leucine (Leu) to proline (Pro) within the carboxy-terminal MyTH4 domain in the
proteins’ tail region. Myo15 mRNA was expressed in the retina as demonstrated for the first time with the help of in-situ
hybridization and PCR. To characterize the visual phenotype, rats were examined by scotopic and photopic
electroretinography and, additionally, histological analyses of the retinas were conducted. The complete loss of sight
was detected along with a severe degeneration of photoreceptor cells. Interestingly, the manifestation of the disease does
not solely depend on the mutation, but also on environmental factors. Since the LEW/Ztm-ci2 rat features the entire range
of symptoms of the human Usher syndrome we think that this strain is an appropriate model for this disease. Our findings
display that mutations in binding domains of myosin XV do not only cause non-syndromic hearing loss but can also lead to
syndromic disorders including retinal dysfunction.
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Introduction
The LEW/Ztm-ci2 rat (ci=circling), previously described as an
animal model for syndromal deafness, arose as a spontaneous
mutation in the inbred strain LEW/Ztm in 1991. The mode of
inheritance of the deviant phenotype is autosomal recessive. In
addition to deafness, the animals show spontaneous lateralized
circling behavior, stargazing, locomotor hyperactivity, moderate
ataxia and the inability to swim. Motor abnormalities can either be
induced through stress or occur spontaneously [1]. The symptoms
manifest during the first three weeks of life. Histological analysis of
the inner ear revealed that the organ of Corti, which includes
inner and outer hair cells, is completely absent or occasionally
reduced. However, inner hair cells and outer hair cells of the
vestibular organs are both present. Characteristic effects in this
area are shortened stereocilia, a lower number of ganglion cells
and a reduced thickness of axons [2].
There are a number of mouse and rat strains that show a
phenotype similar to the LEW/Ztm-ci2 rat such as the shaker-2
mouse (STOCK Myo15
sh2/J), which incidentally carries a
mutation in the Myo15 gene [3].
Myosin XV is assigned to a protein family, namely the
unconventional myosins, which are involved in various cellular
functions such as cell motility, cytoplasmatic transport and
movement processes, endocytosis and exocytosis, regulation of
ion channels and also play an important role within the actin
cytoskeleton [4–7]. Function of the myosin XV protein includes
the maintenance of actin organization in hair cells of the organ of
Corti. Therefore, it seems to be critical for the normal cytoskeletal
morphology [3].
In humans, mutations in Myo15 cause the non-syndromic
autosomal recessive profound hearing loss disorder (DFNB3) [8,9].
Mutations in some of the other unconventional myosins, such as
myosin VI and VIIa, have also been reported to be responsible for
hereditary deafness in humans, mice and rats [10–12,13].
The shaker-1 (STOCK Myo7a
sh1/J) mouse and the tornado rat
(Crl:WI-Myo7a
tnd) are further examples for strains showing
phenotypes comparable to LEW/Ztm-ci2 rats. In both cases the
underlying mutations were traced to the Myo7a gene [13,14].
MYO7A is one of several genes responsible for the human Usher
syndrome (USH) [15]. This is a clinically variable human disease,
with an autosomal recessive mode of inheritance, characterized by
congenital sensorineural hearing loss, vestibular dysfunctions and
visual impairment. The disease is caused by several mutations in
proteins integrated in the Usher protein network. The syndrome
has three distinct clinical subtypes [16] referred to as USH1,
USH2, USH3, which vary in the severity of disease manifestation
with USH1 being the most severe form. Patients suffer from
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deficiency) and a prepubertal onset of retinitis pigmentosa. The
latter is characterized by a progressive degeneration of the retinal
photoreceptor cells [17] that leads to night blindness and visual
field loss over the course of several decades [18,19].
We were able to identify the mutation causing the deviant
phenotype of the LEW/Ztm-ci2 rat in the Myo15 gene. During our
study we only observed the retinal phenotype in some animals and
believe that it is dependent on environmental factors. Our findings
confirm what was already suggested by Gockeln et al., 2003 and
Lo ¨scher et al., 2009/2010 [20–22]: The LEW/Ztm-ci2 rat is a
valuable animal model for the human Usher syndrome.
Materials and Methods
Animals
Homozygous LEW/Ztm-ci2 rats of both genders were used and
all animals originated from the CAF breeding colony. The
coisogenic background strain LEW/Ztm (F122/123) served as
control. Age of animals used for electrophysiological or histological
investigations ranged between 400 and 750 days, with an average
of 550 days.
Husbandry and experiments were in accordance with the
German Animal Welfare Legislation (Tierschutzgesetz: http://
foundation.aalas.org/). All experiments were also approved by
the local Institutional Animal Care and Research Advisory
Commitee and by the local government, namely the Lower
Saxony State Office for Consumer Protection and Food Safety
(approval ID: 509c-42502-03/651).
Husbandry
Animals were kept in a controlled environment with a
temperature of 2262uC, relative humidity of approximately
55%, and artificial light from 5:30 h to 19:30 h. The rats were
kept on a sterilized commercial softwood granulate bedding
(Lignocel, Altromin; Lage, Germany) and received commercial
pellet diet (Altromin, 1314) and water ad libitum. Rats were kept
alone, as pairs, or as sibling groups in wire-topped type III
MacrolonH cages (Techniplast, Italy) in Hannover Medical
School. In the University of Veterinary Medicine Hannover
animals were kept alone. Microbiological status was monitored
according to the FELASA recommendations [23]. In both facilities
mutant (LEW/Ztm-ci2) and control (LEW/Ztm) strains were
housed in the same rooms under the same conditions.
DNA isolation
For tissue collection, animals were sacrificed by cervical
dislocation after anesthesia with CO2. Lysis of tissue samples
(ear, tail) was prepared overnight at 55uC in 400 ml lysis buffer,
containing 100 mM Tris (pH 8.5), 200 mM of NaCl, 0.2% of
SDS, 5 mM of EDTA, and 100 mg/ml of freshly added Proteinase
K. Samples were centrifuged for 15 min at 6000 g and the
supernatant was transferred to a fresh tube or plate. Genomic
DNA was isolated by adding an equal amount of isopropanol,
mixing and subsequent centrifugation for 20 min at 6000 g. Pellets
were rinsed with 70% ethanol and dissolved in 400 mlH 2O. For
PCR, 5 ml of a 50 fold dilution in water was used.
PCR and sequencing
Resequencing of all exons of Myo15 and of Kcnj12 was
performed using LIMSTILL, LIMS for Induced Mutations by
Sequencing and TILLing (http://limstill.niob.knaw.nl). LIM-
STILL was used to generate the Myo15 project and visualize the
gene structure based on Ensembl file ENSRNOG00000028597.
The primer design application within LIMSTILL is Primer3-
based and parameters are set to design primers with an optimal
melting temperature of 58uC.
PCR was performed using a touchdown thermocycling program
(92uC for 60 sec; 12 cycles of 92uC for 20 sec, 65uC for 20 sec
with a decrement of 0.4uC per cycle, 72uC for 30 sec; followed by
20 cycles of 92uC for 20 sec, 58uC for 20 sec and 72uC for 30 sec;
72uC for 180 sec; GeneAmp9700, Applied Biosystems). PCR
reaction mixes contained 5 ml genomic DNA, 0.2 mM forward
primer and 0.2 mM reverse primer, 200 mM of each dNTP,
25 mM Tricine, 7.0% Glycerol (w/v), 1.6% DMSO (w/v), 2 mM
MgCl2, 85 mM Ammonium acetate pH 8.7 and 0.2 U Taq
Polymerase in a total volume of 10 ml.
PCR products were diluted with 20 ml water and 1 ml was used
as template for the sequencing reactions. Sequencing reactions,
containing 0.25 ml BigDYE (v1.1; Applied Biosystems, Nieuwer-
kerk a/d IJssel, The Netherlands), 3.75 ml 2.56 dilution buffer
(Applied Biosystems) and 0.4 mM gene specific primer in a total
volume of 10 ml, were performed using cycling conditions
recommended by the manufacturer. Sequencing products were
purified by ethanol precipitation in the presence of 40 mM
sodium-acetate and analyzed on a 96-capillary 3730XL DNA
analyzer (Applied Biosystems). Sequences were analyzed using
PolyPhred [24].
Real Time PCR
RNA was isolated using the RNeasy Lipid Tissue Mini Kit
(Qiagen) according to manufacturers’ instructions. Pituitary gland
tissue from LEW/Ztm and LEW/Ztm-ci2 rats as well as retina
tissue collected from LEW/Ztm rats were disrupted and
homogenized in QIAzol Lysis Reagent. Then, from 1 mgo f
RNA, cDNA was synthesized using the Omniscript Reverse
Transkription Kit (Qiagen) according to the manufacturer’s
recommendations. Primers for the Myo15 fragment were designed
using the Oligo 6 program (Molecular Biology Insights); primer:
Myo15-mRNA fw 59.ACCTGCCCAGTGTGCGTGAG,39,
Myo15-mRNA rev 59.TGGTGGGGACTGAG TGCCTG,39.
Reaction mixes contained 10 ng cDNA, 2,5 ml biotherm Buffer
(with 15 mmol MgCl), 1,5 ml of each primer (10 mM), 0,5 ml
dNTP’s (10 mM), 2 ml SYBRH Green, 1 U Biotherm Taq in a
total volume of 25 ml. Reaction was done using the opticon cycler
(MJ Research) with the following cycling conditions: 95uC for
3 minutes, 40 cycles of 95uC for 30 sec., 67,7uC for 30 sec. and
72uC for 30 sec. followed by 72uC for 10 min. Amplified DNA
fragments were separated by electrophoresis using 3:1 Biozym
Sieve agaroseH (Biozym).
Electroretinography (ERG)
All procedures involving animals adhered to the Association for
Research in Vision and Ophthalmology statement for the use of
animals in ophthalmic and vision research. Electroretinograms
were recorded according to the standard of the International
Society for Clinical Electrophysiology of Vision [25]. The ERG
equipment comprised a Ganzfeld bowl, a DC amplifier and a PC-
based control and recording unit (Roland Consult, Brandenburg/
Wiesbaden, Germany).
Rats were dark-adapted overnight (at least 12 hours). Pupils
were dilated using 2,5% phenylephrine and 1% tropicamide,
which was administered 20 minutes before measurement. Rats
were anesthetized with a mixture of Ketaminhydrochloride
(100 mg/kg BW i.p.) and Xylazine (4 mg/kg BW i.p.). Needle
electrodes, subcutaneously placed, served as reference (ear base)
and ground (tail base) electrodes.
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circular gold-wire loop electrodes were placed over the bulbi. All
procedures were carried out in absolute darkness using red light.
Scotopic (rod) recordings were performed with a series of white
single flashes with six increasing stimulus intensities reaching from
0.01 to 30.0 cds/m
2. On each level 3 to 5 flashes were recorded
with a frequency of 0,2 to 0,1 Hz and averaged. Interstimulus
intervals between levels lasted 30 sec. In a second step, rats were
light adapted for 10 minutes with a background of 25 cd/m
2.
Photopic (cone) responses were recorded with a series of five
increasing stimulus intensities of 3.0 cds/m
2 up to 100 cds/m
2.
The a-wave amplitude was measured from the prestimulus
baseline to the minimum value of the first negative deflection.
The b-wave values were measured from the trough of the a-wave
to the maximum positive value.
Histology
For histological evaluations, eyes were fixed in glutaraldehyde.
After dehydration in a graded ethanol series (10%, 30%, 50%,
70%, 80%, 90%, 95% and absolute ethanol), the tissues were
embedded in Technovit 7100 (Heraeus Kulzer, Wehrheim,
Germany) according to the manufacturer’s recommendation.
After infiltration with infiltration solution (hardener 1 and
Technovit 7100) for 12 h, the eyes were cut into halves along
the line of the optic nerve and embedded in Histoform S according
to the manufacturer’s recommendation. Microtomy was executed
strictly perpendicular to the retinal surface. Serial sections of 1–
3 mm were stained with haematoxylin (Gill) and eosin.
Comparison of environmental factors
Microbiological monitoring was performed according to
FELASA recommendations [23]. Light intensity was measured
in different locations in the room and in three different rack levels
(top row, bottom row and middle row) in front of the cages and
inside the cages. For analysis an illuminance meter (roline digital
luxmeter) was used.
In situ hybridization Myo15 mRNA
Eyes were postfixed in 4% paraformaldehyde for 24 h at 4uC
and embedded in paraffin. The following antisense oligonucleotide
probe was used: 59-CATCGTCATCCGCTTCCCCGGAC-
GACGCGG-39. The 59-end digoxigenin-labeled probe recognizes
Myo15 and was obtained from MWG-Biotech AG (Ebersberg,
Gemany). A corresponding sense oligo-probe was used as control.
Deparaffinized, lightly dried 4 mm sections were rinsed in TBS,
200 mM HCl, and 0.5% acetic anhydride for 20 min, followed by
a digestion with 0.1% proteinase K for 30 min at 37uC. Slides
were rinsed again in TBS, dehydrated in ascendant concentrations
of ethanol, and stretched at 95uC for 5 min. Sections were
hybridized at 45uC for 18 h, followed by washings with 26SSC
(standard saline citrate) for 3620 min, 50% formamide (in SSC)
for 3620 min at 55uC and 16SSC for 2615 min. Afterwards
slides were incubated with anti-DIG AP for 30 min and NBT/
BCIP for 2 h (DIG Nucleic Acid Detection Kit, Roche Diagnostics
GmbH, Mannheim, Germany). Slides were viewed with an
Axioplan 2 imaging microscope (Zeiss, Jena, Germany) for in situ
mRNA expression.
Results
The mutation of the LEW/Ztm-ci2 rat was traced to a
base substitution in exon 56 of Myo15
In a previous study a genome-wide scan of a (LEW/
Ztm-ci26BN/Ztm) F16LEW/Ztm-ci2 backcross population
demonstrated a strong association of the circling 2 phenotype
with a region localized centrally in RNO10. Rat BAC clones were
used to create a physical map of this region of interest. Two
candidate genes, Myo15 and Kcnj12, were selected based on their
genomic localization and involvement in a similar pathology in
human and mouse [26].
To identify the mutation we resequenced exons of both genes
using PCR and conventional dideoxy sequencing. Two non-
reference alleles of Myo15 were identified by comparing sequences
of the mutated rat strain LEW/Ztm-ci2 and its co-isogenic
background strain LEW/Ztm. The detected base substitution
from T to C at position 43612 in exon 56 leads to an amino acid
change from leucine to proline (L3157P) within the carboxy-
terminal MyTH4 (myosin tail homology-4) domain of the protein
(Fig. 1). The leucine residue at position 3157 is conserved
throughout the vertebrate lineage, according to MultiZ alignments
in the UCSC Genome Browser (http://ucsc.genome.gov). The
PolyPhen program predicted this amino acid change to be
‘‘possibly damaging’’ to protein function. Resequencing of Kcnj12
revealed no additional mutation.
Expression of Myo15 transcripts
To determine whether the base pair substitution affects Myo15
mRNA expression in general, a Real Time PCR of a Myo15
specific fragment was carried out. RNA was extracted from the
pituitary gland of LEW/Ztm-ci2 and LEW/Ztm rats as the highest
Myo15 RNA expression has been reported for this tissue [27].
Myo15 signals were normalized against beta-actin signals. The
results indicate that there are no significant differences in Myo15
transcript levels in the pituitary glands of the LEW/Ztm-ci2 rat
compared to rats of the LEW/Ztm background strain.
Electroretinographic investigations indicated an
involvement of the visual system
Behavioral observations of some LEW/Ztm-ci2 rats using
several screening techniques for sensory functions [28,29] and
preliminary electrophysiological investigations indicated that the
vision might be impaired (pers. comm., v. Ho ¨rsten, data not
shown) [20]. To characterize the eye phenotype of this strain, an
electroretinographic survey of LEW/Ztm-ci2 rats (n=7 per group)
and LEW/Ztm rats (n=7 per group) was carried out. Owing to its
results, animals were subdivided into two groups. One group
included only animals that were born, raised and maintained at
the Central Animal Facility of Hannover Medical School (group
MedSchool) for their entire life. In this group, the electrophysi-
ological examinations of LEW/Ztm-ci2 rats and LEW/Ztm
control rats solely revealed physiological responses (Fig. 2, 3-A/C).
Animals of the second group were also born and raised in the
Central Animal Facility of Hannover Medical School, however,
they were at some point transferred and then housed in the
University of Veterinary Medicine Hannover (group VetSchool).
All LEW/Ztm-ci2 rats showed decreased responses of the
photoreceptor cells, both rods and cones (Fig. 2, 3, Table 1),
which means that the incidence of the retinal phenotype was 100
percent. A complete loss of responses was observed in 36% (Fig. 3-
B). In contrast, electroretinograms of LEW/Ztm control rats
appeared normal (Fig. 2, 3-D, Table 1).
Retinal degeneration was discovered by histological
examination
Electroretinography is an appropriate method for the early
detection of retinal alterations as morphological changes usually
do not appear until ERG responses are dramatically reduced. Due
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ci2 animals of the VetSchool group we examined the eyes
histologically. Three eyes of LEW/Ztm-ci2 rats and LEW/Ztm
rats were looked at per group (MedSchool, VetSchool), 12 samples
in total. All samples in LEW/Ztm-ci2 rats from the VetSchool
group showed some degree of pathological alteration ranging from
a diminution to a complete loss of the photoreceptor cell layer and
the outer nuclear layer (Fig. 4-B/C). Interestingly, the remaining
cell layers (inner nuclear layer, inner and outer plexiform layers)
and the retinal pigment epithelium appeared intact. In contrast,
none of the LEW/Ztm-ci2 and LEW/Ztm rats of the MedSchool
group showed any signs of photoreceptor degeneration (Fig. 4-A).
Myo15 transcripts were detected in retinas by in situ
hybridisation and by Real Time PCR
Retina sections of affected and unaffected LEW/Ztm-ci2
animals were hybridized with a 59-end digoxigenin-labeled probe
that recognizes the Myo15 mRNA in a region not harboring the
mutation. Myo15 transcripts were detected in the retinas of
affected (Fig. 5) and unaffected animals. Probe binding was
discovered in all retinal layers but to a higher degree in the Outer
Plexiform Layer and in the Inner Photoreceptor Cell Layer.
Myo15 mRNA was detected in retinas of LEW/Ztm rats by
PCR techniques (Fig. 6).
Differences in environmental conditions of both facilities
(MedSchool/VetSchool) did not seem to disturb the
vision
LEW/Ztm-ci2 rats from two facilities display diverging eye-
phenotypes. As all animals originate from the same stock of an
inbred strain the environmental conditions must be the cause for
these disparities. Environmental factors certainly have the
potential to cause retinal damage. Excessive light exposure, for
example, can cause severe retinal degeneration, particularly in
albino rats [30,31]. The light intensity as well as the duration of
light (enlarged light cycle) play a decisive role.
Since unaffected control animals were housed along with
affected LEW/Ztm-ci2 rats, the environmental factors alone
cannot be responsible for the retinal phenotype of LEW/Ztm-ci2
rats. Nevertheless, all factors that have the potential to harm
retinal structures were investigated in both facilities.
Microbiological monitoring did not reveal an infection with
common rat pathogens except for Staph. aureus, Pasteurella
pneumotropica, Helicobacter sp. (MedSchool and VetSchool); Coryne-
bacterium sp., Rat Parvo Virus (MedSchool); and Oxyura syphacica muris
(VetSchool). Borna disease virus wasn’t detected in either of the
faculties. Furthermore, previous or acute infections were excluded
by histological examination of the retinas and by blood tests.
The light intensity measured in the middle of the animal room,
in front of the cages and inside the cages, was for the most part
comparable between facilities (Table 2). However, the room of the
VetSchool was illuminated in a very uneven way. The light
intensity inside all cages ranged from 2 to 28 lux, however,
130 lux were observed in the top row of the female’s rack in the
room of the VetSchool.
Additional environmental factors (such as diet, water supply,
bedding, light cycle etc.) did not differ between both facilities.
Discussion
In this study we describe the first rat strain carrying a mutation
in Myo15. Phenotypic features of homozygous LEW/Ztm-ci2
animals are deafness and spontaneous lateralized circling behavior
combined with further motor abnormalities such as stargazing,
locomotor hyperactivity and ataxia [1]. Previously, histological
Figure 1. Illustration of the LEW/Ztm-ci2 mutation in the MyTH4 domain of the Myo15 gene. (A) Polyphred view of the single point
mutation found in exon 56 in the C-terminal MyTH4-domain. (B) The base substitution (TRC) does not cause a stop codon but leads to an exchange
of the amino acid Leucin for Proline at position 3157 in the Myosin XV protein.
doi:10.1371/journal.pone.0015669.g001
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the vestibular organs are damaged or lacking [2]. The mutation
has been mapped to a region on rat chromosome 10, including
strong candidate genes Myo15 and Kcnj12.
Resequencing of these candidate genes revealed a base
substitution (TRC) in exon 56 of Myo15 causing an amino acid
exchange in the C-terminal MyTH4 domain of myosin XV.
Myo15 transcript levels are comparable between mutant and wild-
type animals, indicating that the protein function of myosin XV
must be altered. According to the recommendations of the rat
genome and nomenclature committee this model is now
denominated LEW/Ztm-Myo15
ci2 rat.
Recessive mutations in MYO15A are associated with the
profound nonsyndromic hearing loss disorder (DFNB3) in humans
[8,9]. Previously described mutant allels of MYO15A are
distributed across the length of the gene. A number of DFNB3
causing mutations have been identified and are mainly located in
the motor region [8,9] but also in the N-terminal MyTH4 and
FERM domains of the protein’s tail [32,33]. Only recently a
missense mutation (L3160F) in the C-terminal MyTH4 domain of
myosin XV was detected in a Pakistani family. Although this
mutation is located close to the circling-2 mutation the only
symptom reported in humans is deafness [32].
The tail domains of myosin XV have several binding sites that
interact with other proteins. The co-localization of the myosin
XV and whirlin proteins is thought to be a key event for
stereocilia elongation [34,35]. The PDZ domain of whirlin
binds to the C-terminal MyTH4-FERM region of myosin XV
[34]. As this is the same myosin XV region where the circling-2
mutation occurred, we think it is possible that the binding site is
affected.
The mutation in the third PDZ domain of whirlin in humans
causes the sensorineural deafness disorder (DFNB31). A homolo-
gous mutation in the whirlin gene (Whrn) in a mouse strain results
in a phenotype very similar to that of the shaker-2 mice and
circling-2 rats [36–39].
Whirlin is part of a protein network performing several
functions in neurosensory cells of the retina and the cochlea. It
links proteins that are involved in the Usher syndrome, such as
myosin VIIa, harmonin b, cadherin-23, protocadherin-15 and
VLGR1b [40]. This Usher interactome participates in common
pathways of the inner ear and the retina that are disrupted in the
Usher syndrome [41]. However, the biochemical and structural
mechanism governing the Usher protein complex formation
remains largely unclear.
Several rodent strains have been suggested as animal models for
the human Usher syndrome (Subtype 1B), for example the shaker-
1 mouse (STOCK Myo7a
sh1/J) and the tornado rat (Crl:WI-
Myo7a
tnd), respectively. Both animal models show circling behav-
ior, vestibular dysfunctions and profound deafness. However,
Figure 2. Mean values of rod responses recorded by electroretinography. Average skotopic a- and b-wave maximum amplitudes elicited by
a 3 cds/m
2 light stimulus. (A) a-wave amplitudes of the left eyes of LEW/Ztm-ci2 (ci2) rats from two different hygienic units, MedSchool (MHH) and
VetSchool (TiHo) and corresponding controls (K) (B) a-wave amplitudes of the right eyes (C) b-wave amplitudes of the left eyes (D) b-wave
amplitudes of the right eyes; responses of ci2 mutants of the VetSchool group are strongly increased compared to controls and mutant rats of the
MedSchool group *significant differences compared to controls p,0.05 are indicated with an asterix.
doi:10.1371/journal.pone.0015669.g002
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retina, as can be seen in USH1-patients, have not been described.
So far, an involvement of myosin XV in the human Usher
syndrome (USH) has not been established. However, myosin XV
interacts with whirlin - a protein known to be involved in the
Usher syndrome (USH2D). Whirlin plays a central role in the
Usher protein network, which consists of at least nine different
proteins [41,42]. Since myosin XV is responsible for the
transportation of whirlin in the inner ear, a similar function might
be imaginable in the retina. To investigate the expression of
myosin XV mRNA in the eye, a Real Time PCR and an in-situ
hybridization were performed. Being able to demonstrate the
expression of Myo15 mRNA in rat eyes for the first time we went
ahead and examined whether the LEW/Ztm-Myo15
ci2 rat exhibits
a retinal phenotype.
Previous studies indicated that the visual system is affected in
some of the LEW/Ztm-Myo15
ci2 rats (pers. comm., v. Ho ¨rsten).
Electroretinographical and histological investigations revealed that
the loss of function is caused by the degeneration of the retina
(Fig. 2, 3). We hypothesize that the mutant form of myosin XV in
LEW/Ztm-Myo15
ci2 rats is not able to bind to its partner proteins
(e.g. whirlin) in the retina and thereby reduces their functions.
Interestingly, LEW/Ztm-Myo15
ci2 rats could be subdivided into
two groups depending on housing: one susceptible to retinal
damage and the other resistant.
In the group housed in the VetSchool the incidence of a retinal
phenotype was 100 percent. Histological evaluation revealed a
degeneration of the retinas in the affected eyes. The RPE and the
inner retina seemed to be totally unaffected, while the outer retina
was almost completely disintegrated with only a few photoreceptor
cell somata remaining. These findings are very similar to those
revealed in a mouse model for Usher syndrome type 2A, described
by Liu et al. 2007 [43]. In this mouse model, reduced ERG
amplitudes and retinal degeneration were detected solely in aged
animals. This finding has also been demonstrated in our LEW/
Ztm-Myo15
ci2.
Surprisingly, none of the LEW/Ztm-Myo15
ci2 animals of the
MedSchool group showed any signs of impaired vision. Therefore,
the question arose: Which factors could be responsible for
inducing the retinal phenotype in LEW/Ztm-Myo15
ci2 rats?
A new genetic defect can be excluded since all animals were
born in the same breeding colony in the Central Animal Facility of
Hannover Medical School and some even stem from the same
breeding pair. The only difference between these animals was their
environment. Since control animals, which were kept under the
same environmental conditions did not show any signs of retinal
impairment, the environmental factors alone could not be held
responsible for the retinal phenotype in LEW/Ztm-Myo15
ci2 rats.
Comparison of environmental conditions revealed some differ-
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Figure 3. Scotopic electroretinography (ERG) recordings. Electroretinographic responses in (A) an unaffected LEW-ci2 rat (MedSchool), (B)a n
affected LEW-ci2 rat (VetSchool) with extinct curve (no response), (C/D) corresponding, unaffected controls (MedSchool/VetSchool), exemplary for
the whole groups. Recorded by a stimulus with a light intensity of 3 cd s/m
2. N=basic value, a=a-wave, b=b-wave, Time=implicit time.
doi:10.1371/journal.pone.0015669.g003
LEW-ci2 Rats Reflect Symptoms of the Usher Disease
PLoS ONE | www.plosone.org 6 March 2011 | Volume 6 | Issue 3 | e15669ences between the two facilities but so far it has not been possible
to pinpoint to any obvious factors affecting the animals’ sight.
Involvement of certain pathogens, e.g. coronavirus or Borna
disease virus, has been reported in retinal degenerations [44,45]
and the rats were examined for the most important pathogens,
however, none with relevance were detected. The light intensity
was another factor that was closely watched since albino rats easily
suffer retinal damages from increased light intensities. Therefore,
the maximum light intensity for albino rat strains is recommended
to be 60 lux (www.gv-solas.de/auss/hal/rattenhaltung.pdf). In the
MedSchool the light intensity inside the cages ranged between 2
and 6 lux. In the VetSchool intensities of 6 to 28 lux were
measured, with the exception of the top row of the female’s rack
where a light intensity of 130 lux was observed (Table 2).
Furthermore, in the animal room of the VetSchool the
Figure 4. Histological examinations of retinae from unaffected and affected LEW/Ztm-ci2 rats. (A.) Unaffected LEW/Ztm-ci2 rat
(MedSchool group) showing slight reduction of photoreceptor cells due to age (B.) Affected LEW/Ztm-ci2 rat (VetSchool group) with distinct
reduction of number and density of rod and cone somata within the ONL (C.) Severely affected LEW/Ztm-ci2 rat (VetSchool group) cell bodies, inner
and outer segments of photoreceptor cells are nearly absent while the remaining retinal layers are arranged in a normal pattern (6400) NF=Nerve
fibres, IPL=Inner Plexiform Layer, INL=Inner Nuclear Layer, OPL=Outer Plexiform Layer, ONL=Outer Nuclear Layer, PRC=Inner and Outer Segments
of Photoreceptor Cells, RPE=Retinal Pigment Epithelium.
doi:10.1371/journal.pone.0015669.g004
Figure 5. In situ hybridization in a paraffin section of a LEW/
Ztm-ci2 rat indicates the presence of Myo15 mRNA in the retina.
The insert demonstrates the same retina with the sense-control. (680)
IPL=Inner Plexiform Layer, INL=Inner Nuclear Layer, OPL=Outer
Plexiform Layer, ONL=Outer Nuclear Layer, PRC=Inner and Outer
Segments of Photoreceptor Cells.
doi:10.1371/journal.pone.0015669.g005
Figure 6. Evidence of Myo15 expression in the rat retina.
Agarose gel results of PCR products obtained from retinas of LEW/Ztm
rats. Lane M contains the DNA ladder; lane 1 contains the negative
control reaction (no cDNA template, Myo15 primers); lane 2 contains
cDNA (10 ng) obtained from the retina (Myo15 primers, expected
length of the fragment 125 bp); lane 3 contains positive control, cDNA
(10 ng) obtained from the pituitary gland (Myo15 primers, expected
length of the fragment 125 bp); lane 4 contains negative control
reaction (no cDNA template, ß-Actin primers); lane 5 contains cDNA
obtained from the retina (ß-Actin primers, expected length of fragment
101 bp).
doi:10.1371/journal.pone.0015669.g006
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than the rest.
A correlation between the light intensity and severity of retinal
degeneration was assumed as electroretinographical responses
were slightly less in affected females than in males. However,
functional or structural differences between animals kept in
different rows and therefore at different light intensities were not
observed. Since the impact of light intensities on the development
of the retinal phenotype in LEW/Ztm-Myo15
ci2 rats remained
unclear, this factor should be closely examined in further studies.
Based on these observations, we assume that the susceptibility to
impaired vision is mediated by the interaction of the mutated
Myo15 gene, the genetic background and unknown environmental
factors. The relevance of environmental factors for the develop-
ment of retinal syndromes has been discussed for a long time. In
the human Usher syndrome intrafamilial and interfamilial
variations of retinal impairment have been reported, thereby
indicating an involvement of genetic and non-genetic modifiers in
disease expression [46]. A study by Liu et al. [47] indicates that
even in humans clinical progression is influenced by environmen-
tal factors: monozygotic twins from an atypical USH family
showed differences in the course of the disease and the severity of
symptoms. Therefore, the varying phenotypes of humans, mice
and rats harboring mutations in the C-terminal region of myosin
XV might be due to different environmental conditions. Not only
the retinal but also the vestibular phenotypes are absent in human
patients.
Results of our study might provide insights on the question why
the retinal phenotype in USH-patients and in USH-animal models
follow such a variable course of disease. Our results suggest that
retina degeneration manifests in a mutation-environment combi-
nation, most likely only affecting older animals. Therefore, to
investigate the retinal phenotype in models of the human Usher
syndrome we suggest using older animals housed in diverse
environmental conditions.
In conclusion, the LEW/Ztm-Myo15
ci2 rat exhibits character-
istic features of the human Usher syndrome. In contrast to most of
established animal models for USH, the LEW/Ztm-Myo15
ci2 rat
shows a retinal phenotype including photoreceptor degeneration,
which is modified through currently unknown environmental
factors. Consequently, this strain is an appropriate animal model
for the investigation of the role of Myo15 in human Usher
syndrome, particularly for the investigation of the interaction
between the mutation and environmental factors in modifying
retinopathy.
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